Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
letter
. 1986 May;38(5):773–775.

The heterozygote advantage in phenylketonuria.

L I Woolf
PMCID: PMC1684820  PMID: 3717163

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown M. H., Szczech G. M., Purmalis B. P. Teratogenic and toxic effects of ochratoxin A in rats. Toxicol Appl Pharmacol. 1976 Aug;37(2):331–338. doi: 10.1016/0041-008x(76)90096-x. [DOI] [PubMed] [Google Scholar]
  2. Bull H. G., Luhr H. G., Schmidt-Hoberg W. Klinische Ergebnisse der Differentialdiagnostik des sogenannten Gesichtsschmerzes. Zahnarztl Prax. 1974 Apr 19;25(8):194–196. [PubMed] [Google Scholar]
  3. CARTER C. O., WOOLF L. I. The birthplaces of parents and grandparents of a series of patients with phenylketonuria in in south-east England. Ann Hum Genet. 1961 May;25:57–64. doi: 10.1111/j.1469-1809.1961.tb01497.x. [DOI] [PubMed] [Google Scholar]
  4. COHEN B. E., SZEINBERG A., BOICHIS H., BODONYI E. PHENYLKETONURIA IN YEMENITE JEWS. Pediatrics. 1963 Dec;32:1069–1073. [PubMed] [Google Scholar]
  5. Cahalane S. F. Phenylketonuria. Mass screening of newborns in Ireland. Arch Dis Child. 1968 Apr;43(228):141–144. doi: 10.1136/adc.43.228.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Creppy E. E., Schlegel M., Röschenthaler R., Dirheimer G. Phenylalanine prevents acute poisoning by ochratoxina in mice. Toxicol Lett. 1980 Jul;6(2):77–80. doi: 10.1016/0378-4274(80)90171-x. [DOI] [PubMed] [Google Scholar]
  7. Frequency of inborn errors of metabolism, especially PKU, in some representative newborn screening centers around the world: a collaborative study. Humangenetik. 1975 Dec 23;30(4):273–286. [PubMed] [Google Scholar]
  8. Krogh P., Hald B., Plestina R., Ceović S. Balkan (endemic) nephropathy and foodborn ochratoxin A: preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand B. 1977 Jun;85(3):238–240. doi: 10.1111/j.1699-0463.1977.tb01702.x. [DOI] [PubMed] [Google Scholar]
  9. Woolf L. I. A study of the cause of the high incidence of phenylketonuria in Ireland and west Scotland. Ir Med J. 1976 Sep 30;69(15):398–401. [PubMed] [Google Scholar]
  10. Woolf L. I., Cranston W. I., Goodwin B. L. Genetics of phenylketonuria. Heterozygosity for phenylketonuria. Nature. 1967 Mar 4;213(5079):882–883. doi: 10.1038/213882a0. [DOI] [PubMed] [Google Scholar]
  11. Woolf L. I., McBean M. S., Woolf F. M., Cahalane S. F. Phenylketonuria as a balanced polymorphism: the nature of the heterozygote advantage. Ann Hum Genet. 1975 May;38(4):461–469. doi: 10.1111/j.1469-1809.1975.tb00635.x. [DOI] [PubMed] [Google Scholar]
  12. Woolf L. I. The high frequency of phenylketonuria in Ireland and Western Scotland. J Inherit Metab Dis. 1978;1(3):101–103. doi: 10.1007/BF01805682. [DOI] [PubMed] [Google Scholar]
  13. ten Kate L. P. On estimating the actual rate of foetal loss in families with an autosomal recessive disorder and Woolf's data on PKU. Ann Hum Genet. 1978 May;41(4):463–464. doi: 10.1111/j.1469-1809.1978.tb00916.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES